Skip to main content
Top
Published in: BMC Cancer 1/2021

Open Access 01-12-2021 | Thyroid Cancer | Research

Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation

Authors: Catherine B. Jensen, Megan C. Saucke, Susan C. Pitt

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

The 2015 American Thyroid Association guidelines supported active surveillance (AS) as a strategy for managing select low-risk thyroid cancers. Data examining physicians’ attitudes about the acceptability of this option are limited. This study aimed to characterize the barriers and facilitators to implementing AS as perceived by practicing endocrinologists and surgeons in the United States.

Methods

We conducted 24 semi-structured interviews probing physicians’ attitudes toward AS for patients with small, low-risk thyroid cancer. We used deductive content analysis guided by a well-known model of guideline implementation. Analysis characterized concepts and themes related to AS implementation as physician, guideline, or external factors. We performed member checking to validate results.

Results

The most prominent barriers to AS were related to physician factors, although guideline-specific and external barriers were also observed. Physician attitudes towards AS comprised the majority of physician-related barriers, while lack of knowledge about the guideline was also discussed. Participants’ concerns about the potential negative outcomes resulting from observing a cancer were notable as were the lack of confidence in performing and offering surveillance. Beliefs about patient expectations and lack of knowledge about the guideline were also identified as barriers to offering surveillance. Guideline-specific and external barriers included the vagueness of surveillance protocols, lack of data supporting active surveillance, and societal beliefs about cancer. Facilitators of active surveillance included patients’ desire to avoid surgery and shared decision-making.

Conclusions

Barriers and facilitators of active surveillance for low-risk thyroid cancers exist at multiple levels. Strategies to increase adoption of active surveillance should focus on physicians’ attitudes, patient expectations, data supporting surveillance outcomes, and promoting societal-level acceptance of surveillance.
Literature
1.
go back to reference Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020.CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133. https://​doi.​org/​10.​1089/​thy.​2015.​0020.CrossRefPubMedPubMedCentral
14.
go back to reference Yang N, Saucke M, Marka N, et al. Adoption of active surveillance: analysis of a large national cohort of physicians. Thyroid. 2019;29(s1):A177–205.CrossRef Yang N, Saucke M, Marka N, et al. Adoption of active surveillance: analysis of a large national cohort of physicians. Thyroid. 2019;29(s1):A177–205.CrossRef
27.
go back to reference Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma. Thyroid. 2020. https://doi.org/10.1089/thy.2020.0330. Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma. Thyroid. 2020. https://​doi.​org/​10.​1089/​thy.​2020.​0330.
34.
go back to reference Doubleday AR, Saucke MC, Bates MF, Pitt SC. Patient-surgeon decision-making about treatment for very low-risk thyroid cancer. Trends Cancer Res. 2019;14:79–89. Doubleday AR, Saucke MC, Bates MF, Pitt SC. Patient-surgeon decision-making about treatment for very low-risk thyroid cancer. Trends Cancer Res. 2019;14:79–89.
Metadata
Title
Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation
Authors
Catherine B. Jensen
Megan C. Saucke
Susan C. Pitt
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08230-8

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine